130 related articles for article (PubMed ID: 14508307)
1. A model of the ventilatory depressant potency of remifentanil in the non-steady state.
Bouillon T; Bruhn J; Radu-Radulescu L; Andresen C; Cohane C; Shafer SL
Anesthesiology; 2003 Oct; 99(4):779-87. PubMed ID: 14508307
[TBL] [Abstract][Full Text] [Related]
2. Mixed-effects modeling of the intrinsic ventilatory depressant potency of propofol in the non-steady state.
Bouillon T; Bruhn J; Radu-Radulescu L; Andresen C; Cohane C; Shafer SL
Anesthesiology; 2004 Feb; 100(2):240-50. PubMed ID: 14739795
[TBL] [Abstract][Full Text] [Related]
3. The pharmacodynamic effect of a remifentanil bolus on ventilatory control.
Babenco HD; Conard PF; Gross JB
Anesthesiology; 2000 Feb; 92(2):393-8. PubMed ID: 10691225
[TBL] [Abstract][Full Text] [Related]
4. Non-steady State Modeling of the Ventilatory Depressant Effect of Remifentanil in Awake Patients Experiencing Moderate-to-severe Obstructive Sleep Apnea.
Doufas AG; Shafer SL; Rashid NHA; Kushida CA; Capasso R
Anesthesiology; 2019 Feb; 130(2):213-226. PubMed ID: 30247202
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic-pharmacodynamic modeling of the respiratory depressant effect of alfentanil.
Bouillon T; Schmidt C; Garstka G; Heimbach D; Stafforst D; Schwilden H; Hoeft A
Anesthesiology; 1999 Jul; 91(1):144-55. PubMed ID: 10422940
[TBL] [Abstract][Full Text] [Related]
6. No evidence for the development of acute tolerance to analgesic, respiratory depressant and sedative opioid effects in humans.
Angst MS; Chu LF; Tingle MS; Shafer SL; Clark JD; Drover DR
Pain; 2009 Mar; 142(1-2):17-26. PubMed ID: 19135798
[TBL] [Abstract][Full Text] [Related]
7. Piritramide and alfentanil display similar respiratory depressant potency.
Bouillon T; Garstka G; Stafforst D; Shafer S; Schwilden H; Hoeft A
Acta Anaesthesiol Scand; 2003 Nov; 47(10):1231-41. PubMed ID: 14616320
[TBL] [Abstract][Full Text] [Related]
8. Esketamine counters opioid-induced respiratory depression.
Jonkman K; van Rijnsoever E; Olofsen E; Aarts L; Sarton E; van Velzen M; Niesters M; Dahan A
Br J Anaesth; 2018 May; 120(5):1117-1127. PubMed ID: 29661389
[TBL] [Abstract][Full Text] [Related]
9. Determination of the potency of remifentanil compared with alfentanil using ventilatory depression as the measure of opioid effect.
Glass PS; Iselin-Chaves IA; Goodman D; Delong E; Hermann DJ
Anesthesiology; 1999 Jun; 90(6):1556-63. PubMed ID: 10360852
[TBL] [Abstract][Full Text] [Related]
10. Remifentanil by bolus injection: a safety, pharmacokinetic, pharmacodynamic, and age effect investigation in human volunteers.
Egan TD; Kern SE; Muir KT; White J
Br J Anaesth; 2004 Mar; 92(3):335-43. PubMed ID: 14970134
[TBL] [Abstract][Full Text] [Related]
11. Influences of morphine on the ventilatory response to isocapnic hypoxia.
Berkenbosch A; Teppema LJ; Olievier CN; Dahan A
Anesthesiology; 1997 Jun; 86(6):1342-9. PubMed ID: 9197304
[TBL] [Abstract][Full Text] [Related]
12. Spontaneous ventilation with remifentanil in children.
Ansermino JM; Brooks P; Rosen D; Vandebeek CA; Reichert C
Paediatr Anaesth; 2005 Feb; 15(2):115-21. PubMed ID: 15675927
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and pharmacodynamics of remifentanil in volunteer subjects with severe liver disease.
Dershwitz M; Hoke JF; Rosow CE; Michałowski P; Connors PM; Muir KT; Dienstag JL
Anesthesiology; 1996 Apr; 84(4):812-20. PubMed ID: 8638835
[TBL] [Abstract][Full Text] [Related]
14. Modeling the non-steady state respiratory effects of remifentanil in awake and propofol-sedated healthy volunteers.
Olofsen E; Boom M; Nieuwenhuijs D; Sarton E; Teppema L; Aarts L; Dahan A
Anesthesiology; 2010 Jun; 112(6):1382-95. PubMed ID: 20461001
[TBL] [Abstract][Full Text] [Related]
15. An exploration of remifentanil-propofol combinations that lead to a loss of response to esophageal instrumentation, a loss of responsiveness, and/or onset of intolerable ventilatory depression.
LaPierre CD; Johnson KB; Randall BR; White JL; Egan TD
Anesth Analg; 2011 Sep; 113(3):490-9. PubMed ID: 21415430
[TBL] [Abstract][Full Text] [Related]
16. Selective 5-HT(1A)-R-agonist repinotan prevents remifentanil-induced ventilatory depression and prolongs antinociception.
Guenther U; Theuerkauf NU; Huse D; Boettcher MF; Wensing G; Putensen C; Hoeft A
Anesthesiology; 2012 Jan; 116(1):56-64. PubMed ID: 22082683
[TBL] [Abstract][Full Text] [Related]
17. Modeling Respiratory Depression Induced by Remifentanil and Propofol during Sedation and Analgesia Using a Continuous Noninvasive Measurement of pCO2.
Hannam JA; Borrat X; Trocóniz IF; Valencia JF; Jensen EW; Pedroso A; Muñoz J; Castellví-Bel S; Castells A; Gambús PL
J Pharmacol Exp Ther; 2016 Mar; 356(3):563-73. PubMed ID: 26660440
[TBL] [Abstract][Full Text] [Related]
18. [Characterization of dose profile of remifentanil with computer simulation: comparative study with fentanyl and alfentanyl].
Gambús PL; Schnider TW; Minto CF
Rev Esp Anestesiol Reanim; 1998 Oct; 45(8):317-25. PubMed ID: 9847642
[TBL] [Abstract][Full Text] [Related]
19. Intravenous boluses of fentanyl, 1 μg kg⁻¹, and remifentanil, 0.5 μg kg⁻¹, give similar maximum ventilatory depression in awake volunteers.
Gelberg J; Jonmarker C; Stenqvist O; Werner O
Br J Anaesth; 2012 Jun; 108(6):1028-34. PubMed ID: 22440314
[TBL] [Abstract][Full Text] [Related]
20. Noninvasive cardiac output measurement using partial carbon dioxide rebreathing is less accurate at settings of reduced minute ventilation and when spontaneous breathing is present.
Tachibana K; Imanaka H; Takeuchi M; Takauchi Y; Miyano H; Nishimura M
Anesthesiology; 2003 Apr; 98(4):830-7. PubMed ID: 12657842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
